Zobrazeno 1 - 10
of 2 350
pro vyhledávání: '"Fibroscan"'
Autor:
Gracen L, Aikebuse M, Sarraf B, McPhail SM, Russell AW, O’Beirne J, Irvine KM, Williams S, Valery PC, Powell EE
Publikováno v:
Patient Preference and Adherence, Vol Volume 18, Pp 1845-1855 (2024)
Lucy Gracen,1 Melanie Aikebuse,2,3 Babak Sarraf,2– 4 Steven M McPhail,5 Anthony W Russell,6 James O’Beirne,7 Katharine M Irvine,8 Suzanne Williams,9 Patricia C Valery,4,* Elizabeth E Powell2– 4,* 1Department of Gastroenterology and Hepa
Externí odkaz:
https://doaj.org/article/10832f40cbf4427eb527e6f4fc09d346
Autor:
Somaia Mohammed Ali Mahfouz, Fatma Salah eldin Mohamed, Nivine Abdel Moneium Chalabi, Hazem Ibrahim Abdel-Rahman
Publikováno v:
The Egyptian Journal of Radiology and Nuclear Medicine, Vol 55, Iss 1, Pp 1-9 (2024)
Abstract Background The most prevalent persistent parenchymatous liver alterations in healthy individuals are thought to be hepatic steatosis. The liver biopsy is the most crucial procedure for the identification and measurement of hepatic steatosis.
Externí odkaz:
https://doaj.org/article/915a45f278d049bc86c49adee2a84d60
Autor:
Larissa Nixdorf, Lukas Hartl, Stefanie Ströhl, Daniel Moritz Felsenreich, Magdalena Mairinger, Julia Jedamzik, Paula Richwien, Behrang Mozayani, Georg Semmler, Lorenz Balcar, Michael Schwarz, Mathias Jachs, Nina Dominik, Christoph Bichler, Michael Trauner, Mattias Mandorfer, Thomas Reiberger, Felix B. Langer, David Josef Maria Bauer, Gerhard Prager
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Metabolic dysfunction-associated steatotic liver disease (MASLD) and related steatohepatitis (MASH) are common among obese patients and may improve after metabolic/bariatric surgery (MBS). 93 Patients undergoing MBS in 2021–2022 were prosp
Externí odkaz:
https://doaj.org/article/bb5b5f12d8734c4fa7cf92b83afbf7ba
Autor:
Mohamed M. Elhoseeny, Badawy A. Abdulaziz, Mohamed A. Mohamed, Radwa M. Elsharaby, Ghadeer M. Rashad, Amira A. A. Othman
Publikováno v:
BMC Gastroenterology, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Objectives To determine how fetuin-A contributes to diagnosing and assessing MASLD severity. Methods Fifty MASLD patients and fifty healthy control participants were involved in this retrospective case-control research. Abdominal ultrasonogr
Externí odkaz:
https://doaj.org/article/d078042bc4e44e1b8bd65cb0854ea136
Autor:
Jeong-Ju Yoo, Sun Ah Maeng, Young Chang, Sae Hwan Lee, Soung Won Jeong, Jae Young Jang, Gab Jin Cheon, Young Seok Kim, Hong Soo Kim, Sang Gyune Kim
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Managing complications of liver cirrhosis such as varices needing treatment (VNT) and clinically significant portal hypertension (CSPH) demands precise and non-invasive diagnostic methods. This study assesses the efficacy of spleen stiffness
Externí odkaz:
https://doaj.org/article/7abdb348a4f8424bb4aede7fcb466542
Autor:
Charu Sharma, Muhammad Jawad Hashim, Javed Yasin, Mahra Rashid Salim Alnaqbi, Abdulla Saeed Ahmed Alkaabi, Mohammed Saif Mohammed Aldhaheri, Juma Alkaabi, Adnan Agha
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
IntroductionMetabolic dysfunction-associated steatotic liver disease (MASLD) has become a major cause of end-stage hepatic disease worldwide requiring liver transplantation, whereas cardiovascular disease (CVD) remains the leading cause of morbidity
Externí odkaz:
https://doaj.org/article/95e7859d137249178a70980660456732
Publikováno v:
Asian Journal of Medical Sciences, Vol 15, Iss 2, Pp 98-103 (2024)
Background: Hepatitis B infection is a global public health problem. Chronic hepatitis B (CHB) infection leads to complications such as cirrhosis, liver failure, and hepatocellular carcinoma. Effective antiviral therapy significantly improves the sta
Externí odkaz:
https://doaj.org/article/04160b6ba8cc477682018cb352626699
Autor:
Tarang Taghvaei, Hajar Shokri-Afra, Seyed Hassan Emadi Jamali, Hafez Fakheri, Iradj Maleki, Mahboobe Ebrahimi
Publikováno v:
Journal of Mazandaran University of Medical Sciences, Vol 33, Iss 2, Pp 161-170 (2023)
Background and purpose: Non-alcoholic fatty liver disease (NAFLD) is the most common liver disorder worldwide. Fatty liver is more common in patients with metabolic syndrome, obese people, and type 2 diabetic individuals. Liver FibroScan is a non-inv
Externí odkaz:
https://doaj.org/article/d02d3a47bb9c47409282b888efe2b53c
Autor:
Lucia Brodosi, Michele Stecchi, Francesca Marchignoli, Elisabetta Lucia, Lucia Magnani, Valeria Guarneri, Maria Letizia Petroni, Giulio Marchesini, Loris Pironi
Publikováno v:
Eating and Weight Disorders, Vol 28, Iss 1, Pp 1-9 (2023)
Abstract Purpose Very few data exist on the association between metabolic dysfunction-associated steatotic liver disease (MASLD) and eating disorders. The study aimed to evaluate the presence of binge eating disorder (BED), in MASLD subjects. Methods
Externí odkaz:
https://doaj.org/article/3f70fef7612e4c08a5e1966f5b176eb0
Publikováno v:
Revista Colombiana de Gastroenterología, Vol 39, Iss 1 (2024)
Introducción: en el proceso diagnóstico de las enfermedades hepáticas, la historia clínica y el perfil bioquímico hepático son fundamentales. La biopsia hepática es el parámetro de referencia para el diagnóstico, evaluación de la actividad,
Externí odkaz:
https://doaj.org/article/e0a29ebb320b4b1ab51674b0f0ef5014